Three Asian Clients Place Order with Arcam for EBM Systems

Arcam, listed on NASDAQ OMX, has received three separate EBM system orders from three clients in Asia.

”These new orders confirm the importance of the Asian market. There is a large interest in Additive Manufacturing in Asia and we now see how several organizations are planning for and executing important investments in Additive Manufacturing. We are very satisfied with our business in Asia, where we already in 2010 established a local support office in China”, says Magnus René, CEO of Arcam.

The above information has been made public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published on October 24, 2013.

Arcam provides a cost-efficient Additive Manufacturing solution for production of metal components. The technology offers freedom in design combined with excellent material properties and high productivity. Arcam’s market is global with customers mainly in the orthopedic and aerospace industries. The company was founded in 1997 and is listed on NASDAQ OMX Stockholm, Sweden. Head office and production facilities are located in Mölndal, Sweden. Support offices are located in the US, UK, Italy and China.

Arcam AB • Krokslätts Fabriker 27A • SE-431 37 Mölndal, Sweden • 46-31-710 32 00 • www.arcam.com

This information was brought to you by Cision http://news.cision.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.